David DeBell, MD - Clifton, New Jersey 07012

David DeBell, MD is categorized under Doctors in Clifton, NJ .

Business Name: David DeBell, MD
Contact Person: Ally Medical
Address: New Jersey Physicians, LLC
6 Brighton Road, Clifton, New Jersey 07012
Phone Number: (973) 777-7911
Website Address: njpllc.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
Share This Business:
Related Businesses: Lewko Michael MD - Clifton, NJ 07012
Torres Catherine P MD - Clifton, NJ 07012
Rosenberg Gene MD - Clifton, NJ 07012
Pagulayan Lorelane B MD - Clifton, NJ 07012
Pinzon Amabelle MD - Clifton, NJ 07012
Chong Raymond E MD - Clifton, NJ 07012
Mathur Mayank MD - Clifton, NJ 07012
Neurology Group-North Jersey - Clifton, NJ 07012
Ovsjanikovska Natalija MD - Clifton, NJ 07012
Isralowitz David L MD - Clifton, NJ 07012
Jose Ibarbia, MD - Clifton, NJ 07012
Larry Rubin, MD - Clifton, NJ 07012
Boris Reydel, MD - Clifton, NJ 07012
Ian Foxall, MD - Clifton, NJ 07012
Brian Schactman, MD - Clifton, NJ 07012
Robert Lintz, MD - Clifton, NJ 07012
Mehta Sidhartha H MD - Clifton, NJ 07012
Ibarbia Jose D MD - Clifton, NJ 07012
O'Brien Joseph P MD - Clifton, NJ 07012
New Jersey Nurology - Clifton, NJ 07012

The company David DeBell, MD provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for David DeBell, MD, and the business now earns $500.000 to $999.999 per annum.

David DeBell, MD was launched in 0 and is classified under SIC code and category , and NAICS number and grouping . To contact David DeBell, MD, please call Ally Medical with the phone number (973) 777-7911 or visit its single location at New Jersey Physicians, LLC
6 Brighton Road in Clifton, New Jersey 07012.

The location of the single location can also be found using the coordinates 40.864950,-74.161690. Read more details about this business on the webpage njpllc.com or follow the company’s social media accounts, on Twitter and on Facebook.